Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
2nd August 2018
Hematology
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now